Updated
SOPHiA GENETICSSOPH · Healthcare
$7.14+7.85%
Market cap$544M
IndustryHealth Information Services
SOPHiA GENETICS (SOPH) Superinvestor holders
8 of the superinvestors we track hold SOPHiA GENETICS (SOPH) in their latest 13F filings, $102M in total.
Summary
The largest holder is David Blood (Generation Investment Management), with $39M, 0.4% of the portfolio.
In their latest quarter: 4 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| David Blood Generation Investment Management |
Held | 6,789,560 | $39M | 0.4% | Q2 2026 |
| Chuck Royce Royce Investment Partners |
Added | 3,887,743 | $33M | 0.3% | Q3 2026 |
| Chuck Akre Akre Capital Management |
Held | 3,719,140 | $21M | 0.4% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 346,610 | $3M | 0.0% | Q3 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 444,654 | $3M | 0.0% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
Trimmed | 409,073 | $2M | 0.2% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 113,300 | $653,741 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 58,333 | $336,581 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 8 |
| Q1 2026 | 7 |
| Q4 2025 | 7 |
| Q3 2025 | 4 |
| Q2 2025 | 4 |
| Q1 2025 | 3 |
| Q4 2024 | 3 |
| Q3 2024 | 3 |
Questions about SOPHiA GENETICS
Which superinvestors own SOPHiA GENETICS?
8 of the superinvestors we track hold SOPHiA GENETICS (SOPH) in their latest 13F filings, $102M in total. David Blood, Chuck Royce, Chuck Akre, Acadian, Ensign Peak, Eric Marshall.
Who is the largest superinvestor holder of SOPH?
The largest holder is David Blood (Generation Investment Management), with $39M, 0.4% of the portfolio.
From SOPHiA GENETICS's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.